[Is there an increased risk for cardiovascular disease in HIV-infected patients on antiretroviral therapy?]

M Duong1, Y Cottin, M Froidure

  • 1Service des maladies infectieuses, centre hospitalier régional universitaire (CHRU) du Bocage, 21034 Dijon, France.

Annales De Cardiologie Et D'Angeiologie
|January 13, 2004
PubMed

Insights

HIV patients on antiretroviral therapy (ART) face increased cardiovascular disease risk due to metabolic issues. Managing risk factors like hypertension and dyslipidemia is crucial for these individuals.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Growing concern regarding cardiovascular disease (CVD) risk in HIV-infected patients undergoing antiretroviral therapy (ART).
  • Metabolic abnormalities linked to long-term ART use are potential contributors to increased CVD risk.
  • Established CVD risk factors (hypertension, dyslipidemia, diabetes, central obesity) are prevalent in HIV patients on ART.

Purpose:

  • To highlight the association between antiretroviral therapy and cardiovascular disease risk in HIV patients.
  • To identify key metabolic and non-reversible risk factors contributing to CVD in this population.
  • To emphasize the importance of managing cardiovascular risk factors in HIV-infected individuals.

Summary:

  • HIV patients on ART exhibit a higher prevalence of cardiovascular risk factors, including hypertension, dyslipidemia, diabetes mellitus, and central fat deposition.
  • Non-modifiable risk factors such as male sex, age over 40, and family history of premature coronary artery disease, alongside lifestyle factors like smoking and sedentary behavior, further increase CVD risk.
  • While a direct atherogenic effect of HIV or ART is considered unlikely, epidemiological data suggest an elevated risk for coronary artery disease, warranting proactive management.

Impact:

  • Informs clinicians about the heightened cardiovascular risk in HIV patients on ART.
  • Underscores the need for comprehensive screening and management of metabolic and lifestyle-related CVD risk factors.
  • Promotes a proactive approach to cardiovascular health in the management of HIV infection.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...